» Articles » PMID: 36577075

Bone Marrow-derived IGF-1 Orchestrates Maintenance and Regeneration of the Adult Skeleton

Overview
Specialty Science
Date 2022 Dec 28
PMID 36577075
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin-like growth factor I (IGF-1) is a key regulator of tissue growth and development in response to growth hormone stimulation. In the skeletal system, IGF-1 derived from osteoblasts and chondrocytes are essential for normal bone development; however, whether bone marrow (BM)-resident cells provide distinct sources of IGF-1 in the adult skeleton remains elusive. Here, we show that BM stromal cells (BMSCs) and megakaryocytes/platelets (MKs/PLTs) express the highest levels of IGF-1 in adult long bones. Deletion of from BMSCs by Lepr-Cre leads to decreased bone formation, impaired bone regeneration, and increased BM adipogenesis. Importantly, reduction of BMSC-derived IGF-1 contributes to fasting-induced marrow fat accumulation. In contrast, deletion of from MKs/PLTs by Pf4-Cre leads to reduced bone formation and regeneration without affecting BM adipogenesis. To our surprise, MKs/PLTs are also an important source of systemic IGF-1. Platelet-rich plasma (PRP) from mice showed compromised osteogenic potential both in vivo and in vitro, suggesting that MK/PLT-derived IGF-1 underlies the therapeutic effects of PRP. Taken together, this study identifies BMSCs and MKs/PLTs as two important sources of IGF-1 that coordinate to maintain and regenerate the adult skeleton, highlighting reciprocal regulation between the hematopoietic and skeletal systems.

Citing Articles

Beclin 1 of megakaryocytic lineage cells is locally dispensable for platelet hemostasis but functions distally in bone homeostasis.

Li L, Zhao C, Zhang R, Wei W, Liu B, Dong J Bone Res. 2025; 13(1):32.

PMID: 40032858 PMC: 11876339. DOI: 10.1038/s41413-025-00410-7.


Signaling Pathways Driving MSC Osteogenesis: Mechanisms, Regulation, and Translational Applications.

Wang L, Ruan M, Bu Q, Zhao C Int J Mol Sci. 2025; 26(3).

PMID: 39941080 PMC: 11818554. DOI: 10.3390/ijms26031311.


Regulation and function of insulin and insulin-like growth factor receptor signalling.

Choi E, Duan C, Bai X Nat Rev Mol Cell Biol. 2025; .

PMID: 39930003 DOI: 10.1038/s41580-025-00826-3.


A framework of biomarkers for skeletal aging: a consensus statement by the Aging Biomarker Consortium.

Suo J, Gan Y, Xie Y, Xu S, Wang J, Chen D Life Med. 2025; 2(6):lnad045.

PMID: 39872060 PMC: 11748998. DOI: 10.1093/lifemedi/lnad045.


Effects of Insulin-like Growth Factor 1 on the Maintenance of Cell Viability and Osteogenic Differentiation of Gingiva-Derived Mesenchymal Stem Cell Spheroids.

Hwa S, Lee H, Ko Y, Park J Medicina (Kaunas). 2025; 61(1).

PMID: 39859058 PMC: 11766960. DOI: 10.3390/medicina61010076.


References
1.
Yakar S, Liu J, STANNARD B, Butler A, Accili D, Sauer B . Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A. 1999; 96(13):7324-9. PMC: 22084. DOI: 10.1073/pnas.96.13.7324. View

2.
Gevers E, Loveridge N, Robinson I . Bone marrow adipocytes: a neglected target tissue for growth hormone. Endocrinology. 2002; 143(10):4065-73. DOI: 10.1210/en.2002-220428. View

3.
Jia D, Heersche J . Insulin-like growth factor-1 and -2 stimulate osteoprogenitor proliferation and differentiation and adipocyte formation in cell populations derived from adult rat bone. Bone. 2000; 27(6):785-94. DOI: 10.1016/s8756-3282(00)00400-2. View

4.
Hu L, Yang G, Hagg D, Sun G, Ahn J, Jiang N . IGF1 Promotes Adipogenesis by a Lineage Bias of Endogenous Adipose Stem/Progenitor Cells. Stem Cells. 2015; 33(8):2483-95. PMC: 4509822. DOI: 10.1002/stem.2052. View

5.
Cheng C, Adams G, Perin L, Wei M, Zhou X, Lam B . Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell. 2014; 14(6):810-23. PMC: 4102383. DOI: 10.1016/j.stem.2014.04.014. View